Free Trial

Alpha Pro Tech (APT) Competitors

$4.87
-0.07 (-1.42%)
(As of 06/7/2024 08:51 PM ET)

APT vs. INGN, LAKE, CLGN, NTRB, MLSS, RBOT, COCH, LFWD, POAI, and HSCS

Should you be buying Alpha Pro Tech stock or one of its competitors? The main competitors of Alpha Pro Tech include Inogen (INGN), Lakeland Industries (LAKE), CollPlant Biotechnologies (CLGN), Nutriband (NTRB), Milestone Scientific (MLSS), Vicarious Surgical (RBOT), Envoy Medical (COCH), ReWalk Robotics (LFWD), Predictive Oncology (POAI), and Heart Test Laboratories (HSCS). These companies are all part of the "surgical appliances & supplies" industry.

Alpha Pro Tech vs.

Inogen (NASDAQ:INGN) and Alpha Pro Tech (NYSE:APT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, community ranking, profitability, risk, media sentiment, earnings and valuation.

Inogen received 373 more outperform votes than Alpha Pro Tech when rated by MarketBeat users. However, 100.00% of users gave Alpha Pro Tech an outperform vote while only 70.44% of users gave Inogen an outperform vote.

CompanyUnderperformOutperform
InogenOutperform Votes
386
70.44%
Underperform Votes
162
29.56%
Alpha Pro TechOutperform Votes
13
100.00%
Underperform Votes
No Votes

Inogen presently has a consensus price target of $7.00, indicating a potential downside of 18.98%. Given Alpha Pro Tech's higher probable upside, analysts clearly believe Inogen is more favorable than Alpha Pro Tech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inogen
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Alpha Pro Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Alpha Pro Tech had 2 more articles in the media than Inogen. MarketBeat recorded 2 mentions for Alpha Pro Tech and 0 mentions for Inogen. Alpha Pro Tech's average media sentiment score of 0.00 beat Inogen's score of -0.45 indicating that Inogen is being referred to more favorably in the media.

Company Overall Sentiment
Inogen Neutral
Alpha Pro Tech Neutral

89.9% of Inogen shares are held by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are held by institutional investors. 1.0% of Inogen shares are held by insiders. Comparatively, 13.6% of Alpha Pro Tech shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Inogen has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500. Comparatively, Alpha Pro Tech has a beta of -0.75, meaning that its stock price is 175% less volatile than the S&P 500.

Alpha Pro Tech has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inogen$315.66M0.65-$102.45M-$4.15-2.08
Alpha Pro Tech$60.91M0.93$4.19M$0.3613.53

Alpha Pro Tech has a net margin of 6.92% compared to Alpha Pro Tech's net margin of -30.07%. Inogen's return on equity of 6.86% beat Alpha Pro Tech's return on equity.

Company Net Margins Return on Equity Return on Assets
Inogen-30.07% -42.87% -28.44%
Alpha Pro Tech 6.92%6.86%6.23%

Summary

Alpha Pro Tech beats Inogen on 10 of the 17 factors compared between the two stocks.

Get Alpha Pro Tech News Delivered to You Automatically

Sign up to receive the latest news and ratings for APT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APT vs. The Competition

MetricAlpha Pro TechSurgical appliances & supplies IndustryIndustrial SectorNYSE Exchange
Market Cap$56.93M$8.54B$9.29B$17.75B
Dividend YieldN/A1.26%2.01%3.56%
P/E Ratio13.5317.9516.9124.96
Price / Sales0.9340.835.3514.10
Price / Cash11.0920.9518.5419.34
Price / Book0.925.553.894.72
Net Income$4.19M$172.21M$456.01M$973.08M
7 Day Performance0.21%-1.26%0.21%0.79%
1 Month Performance-5.07%-2.79%-2.07%0.82%
1 Year Performance28.16%-14.79%3.37%11.00%

Alpha Pro Tech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INGN
Inogen
2.2183 of 5 stars
$8.64
+2.1%
$7.00
-19.0%
-16.6%$203.71M$315.66M-2.08834Gap Down
LAKE
Lakeland Industries
4.6956 of 5 stars
$22.36
+1.4%
$26.00
+16.3%
+67.3%$164.97M$124.69M29.811,750Analyst Forecast
Analyst Revision
News Coverage
CLGN
CollPlant Biotechnologies
1.7138 of 5 stars
$5.13
-3.2%
$11.00
+114.4%
-31.0%$58.75M$10.96M-7.5475Gap Down
High Trading Volume
NTRB
Nutriband
0 of 5 stars
$5.20
-2.6%
N/A+105.5%$57.39M$2.09M-6.753Gap Down
MLSS
Milestone Scientific
0 of 5 stars
$0.73
+1.4%
N/A-35.4%$56.38M$9.83M-7.3017Gap Down
RBOT
Vicarious Surgical
1.6434 of 5 stars
$0.34
-5.6%
$0.67
+99.0%
-84.5%$49.32MN/A-0.883Negative News
Gap Down
COCH
Envoy Medical
0.8696 of 5 stars
$2.40
+13.2%
$6.00
+150.0%
N/A$47.04M$320,000.000.0034News Coverage
Gap Down
LFWD
ReWalk Robotics
2.5894 of 5 stars
$4.60
+0.2%
$13.00
+182.6%
N/A$39.57M$13.85M-1.48108Positive News
POAI
Predictive Oncology
0 of 5 stars
$1.21
-6.9%
N/A-62.1%$4.96M$1.78M-0.3334Gap Down
HSCS
Heart Test Laboratories
0 of 5 stars
$5.83
+1.6%
N/A-94.3%$3.82MN/A-0.1212Gap Down

Related Companies and Tools

This page (NYSE:APT) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners